Annual General Meeting

12 November 2020

Dr Colin Goldschmidt

CEO

Sonic Healthcare Limited

This presentation may include forward-looking statements about our financial results, guidance and business prospects that may involve risks and uncertainties, many of which are outside the control of Sonic Healthcare. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse decisions by Governments and healthcare regulators, changes in the competitive environment and billing policies, lawsuits, loss of contracts and unexpected growth in costs and expenses. The statements being made in this presentation do not constitute an offer to sell, or solicitation of an offer to buy, any securities of Sonic Healthcare. No representation, warranty or assurance (express or implied) is given or made in relation to any forward-looking statement by any person (including Sonic Healthcare). In particular, no representation, warranty or assurance (express or implied) is given in relation to any underlying assumption or that any forward-looking statement will be achieved. Actual future events may vary materially from the forward-looking statements and the assumptions on which the forward-looking statements are based. Given these uncertainties, readers are cautioned to not place undue reliance on such forward-looking statements. The information provided in this presentation is based on and should be read in conjunction with the 2020 Annual Report released to the ASX on 23 September 2020 and may include earnings figures restated on a "constant currency" basis.

This announcement has been authorised by Sonic Healthcare's Company Secretary, whose contact details for further information are as follows:

Paul Alexander

Company Secretary

Sonic Healthcare

Telephone: +61 2 9855 5404

Email: paul.alexander@sonichealthcare.com.au

Sonic Healthcare Limited | 2020 Annual General Meeting

2

12 November 2020

Sonic Healthcare and COVID-19

  • Calendar 2020 - the most challenging year in Sonic's 33-year history
  • Sonic is a global medical laboratory company - occupying a pivotal role in the COVID-19 pandemic
  • Sonic has performed over 11 million COVID-19 PCR tests globally to date
  • The company moved from a challenging position in March/April 2020 back to a position of strength today
  • Response of Sonic's staff has been outstanding - a reflection of Sonic's culture and values
  • Pandemic has brought out the very best in our company - pride, commitment, sense of higher purpose
  • A true demonstration of who we are and what we do
  • A remarkable story of Sonic's staff, operations, financials and contribution to society

Sonic Healthcare Limited | 2020 Annual General Meeting

3

12 November 2020

Sonic's Pandemic Timeline

  • January/February 2020
    • Sonic leaders planning possible pandemic response
    • Staff safety protocols, testing methods, supply chain issues
  • March/April/May 2020
    • Base business volumes and revenue severely impacted
    • Lockdowns, social restrictions, infection fears, cancellation of elective surgery
    • Cost control measures implemented - cash preservation, overtime, furloughs, pay cuts
    • COVID PCR testing - development, validation and commencement
  • June/July/August 2020
    • Progressive recovery in base business volumes and revenue
    • Progressive ramp up of COVID testing, especially USA, Germany, Australia
  • September/October 2020
    • Base business revenue in positive growth, except USA and UK
    • High-volumeCOVID testing in USA, Europe, Australia
  • November 2020
    • Pandemic second waves in Europe and USA
    • Record COVID testing in Europe

Sonic Healthcare Limited | 2020 Annual General Meeting

4

Market Updates

19 February 2020

Release of results for H1 FY 2020

Tracking in line with FY 2020 guidance

20 March 2020

Withdrawal of FY 2020 guidance

Due to uncertainty from pandemic

24 June 2020

Trading Update

Guided to EBITDA A$1.075 million (same as FY 2019)

20 August 2020

Release of full-year FY 2020 results

No FY 2021 guidance - pandemic uncertainty

14 October 2020

Trading Update Q1 FY 2021

Revenue growth up 29%, EBITDA growth up 71%

12 November 2020

AGM

12 November 2020

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Sonic Healthcare Limited published this content on 12 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 November 2020 21:42:00 UTC